The Role of the Immune Phenotype in Tumor Progression and Prognosis of Patients with Mycosis Fungoides: A Quantitative Immunohistology Whole Slide Approach

被引:4
作者
Aulasevich, Natallia [1 ]
Haist, Maximilian [1 ]
Foersch, Sebastian [2 ]
Weidenthaler-Barth, Beate [1 ]
Mailaender, Volker [1 ,3 ]
机构
[1] Johannes Gutenberg Univ Mainz, Dept Dermatol, Univ Med Ctr, D-55131 Mainz, Germany
[2] Johannes Gutenberg Univ Mainz, Inst Pathol, Univ Med Ctr, D-55131 Mainz, Germany
[3] Max Planck Inst Polymer Res, D-55128 Mainz, Germany
关键词
mycosis fungoides; immune phenotype; immunohistochemistry; tumor microenvironment; CD30; prognosis; tumor heterogeneity; T-CELL LYMPHOMA; TRANSFORMATION; FEATURES; EXPRESSION; SURVIVAL; OUTCOMES;
D O I
10.3390/cells11223570
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Background and objectives: Mycosis fungoides (MF) is the most common type of cutaneous T-cell lymphomas, characterized by mature, skin-tropic CD4+ T-helper cells. In order to study the immune tumor microenvironment in MF patients, we performed immunohistochemical stains on MF biopsies, digitized whole-slide tissue sections, and performed quantitative analysis of the different immune cell subsets to correlate tissue parameters with the clinical data of patients, such as progression-free survival or overall survival. Patients and methods: Overall, 35 patients who were treated between 2009 and 2019 and for whom one or more paraffin tissue blocks were available have been included in the present study (58 tissue specimens in total). Conventional immunohistochemistry stains for CD3, CD4, CD8, CD20 and CD30 were used for the analysis of the immune phenotype, and quantitative analysis was performed using QuPath as a quantitative digital pathology tool for bioimage analysis of whole slides. Results: Analysis of tissue parameters for prognostic significance revealed that patients with a stronger infiltration by CD8+ lymphocytes within the tumor cell compartment had a higher risk of disease progression (p = 0.031) and showed a shorter progress-free survival (p = 0.038). Furthermore, a significant association of the percentage of CD30+ cells (median: 7.8%) with the risk of disease progression (p = 0.023) and progression-free survival (p = 0.023) was found. In relation to the clinical features of our patient cohort, a higher risk of disease progression (p = 0.015) and a shorter progression-free survival (p = 0.032) for older patients (>61 years) were observed. Conclusions: Our results demonstrated the prognostic relevance of large-cell transformation in mycosis fungoides and its strong association with the presence of CD30+ lymphocytes. Unlike previous reports, our study suggests an adverse prognostic role for CD8+ T cells in patients with mycosis fungoides. Moreover, our data indicate that the immune phenotype within the tumor microenvironment shows strong temporal heterogeneity and is altered in the course of tumor progression.
引用
收藏
页数:21
相关论文
共 27 条
  • [1] Survival Outcomes and Prognostic Factors in Mycosis Fungoides/Sezary Syndrome: Validation of the Revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer Staging Proposal
    Agar, Nita Sally
    Wedgeworth, Emma
    Crichton, Siobhan
    Mitchell, Tracey J.
    Cox, Michael
    Ferreira, Silvia
    Robson, Alistair
    Calonje, Eduardo
    Stefanato, Catherine M.
    Wain, Elizabeth Mary
    Wilkins, Bridget
    Fields, Paul A.
    Dean, Alan
    Webb, Katherine
    Scarisbrick, Julia
    Morris, Stephen
    Whittaker, Sean J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (31) : 4730 - 4739
  • [2] Long-term outcomes of patients with advanced-stage cutaneous T-cell lymphoma and large cell transformation
    Arulogun, Suzanne O.
    Prince, H. Miles
    Ng, Jonathan
    Lade, Stephen
    Ryan, Gail F.
    Blewitt, Odette
    McCormack, Christopher
    [J]. BLOOD, 2008, 112 (08) : 3082 - 3087
  • [3] QuPath: Open source software for digital pathology image analysis
    Bankhead, Peter
    Loughrey, Maurice B.
    Fernandez, Jose A.
    Dombrowski, Yvonne
    Mcart, Darragh G.
    Dunne, Philip D.
    McQuaid, Stephen
    Gray, Ronan T.
    Murray, Liam J.
    Coleman, Helen G.
    James, Jacqueline A.
    Salto-Tellez, Manuel
    Hamilton, Peter W.
    [J]. SCIENTIFIC REPORTS, 2017, 7
  • [4] Transformed mycosis fungoides: clinicopathological features and outcome
    Barberio, E.
    Thomas, L.
    Skowron, F.
    Balme, B.
    Dalle, S.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2007, 157 (02) : 284 - 289
  • [5] Prognostic factors in transformed mycosis fungoides: a retrospective analysis of 100 cases
    Benner, Marchina F.
    Jansen, Patty M.
    Vermeer, Maarten H.
    Willemze, Rein
    [J]. BLOOD, 2012, 119 (07) : 1643 - 1649
  • [6] CYTOLOGIC TRANSFORMATION IN CUTANEOUS T-CELL LYMPHOMA - A CLINICOPATHOLOGICAL ENTITY ASSOCIATED WITH POOR PROGNOSIS
    DMITROVSKY, E
    MATTHEWS, MJ
    BUNN, PA
    SCHECHTER, GP
    MAKUCH, RW
    WINKLER, CF
    EDDY, J
    SAUSVILLE, EA
    IHDE, DC
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (02) : 208 - 215
  • [7] The biomarker landscape in mycosis fungoides and Sezary syndrome
    Dulmage, Brittany
    Geskin, Larisa
    Guitart, Joan
    Akilov, Oleg E.
    [J]. EXPERIMENTAL DERMATOLOGY, 2017, 26 (08) : 668 - 676
  • [8] CD30 Expression and Proliferative Fraction in Nontransformed Mycosis Fungoides
    Edinger, James T.
    Clark, Beth Z.
    Pucevich, Brian E.
    Geskin, Larisa J.
    Swerdlow, Steven H.
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2009, 33 (12) : 1860 - 1868
  • [9] CD45RA+immunophenotype in mycosis fungoides: clinical, histological and immunophenotypical features in 22 patients
    Fierro, MT
    Novelli, M
    Savoia, P
    Cambleri, I
    Quaglino, P
    Osella-Abate, S
    Bernengo, MG
    [J]. JOURNAL OF CUTANEOUS PATHOLOGY, 2001, 28 (07) : 356 - 362
  • [10] CD8-POSITIVE TUMOR-INFILTRATING LYMPHOCYTES INFLUENCE THE LONG-TERM SURVIVAL OF PATIENTS WITH MYCOSIS-FUNGOIDES
    HOPPE, RT
    MEDEIROS, LJ
    WARNKE, RA
    WOOD, GS
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1995, 32 (03) : 448 - 453